Identification of Differential Tumor Subtypes of T1 Bladder Cancer

Volume: 78, Issue: 4, Pages: 533 - 537
Published: Oct 1, 2020
Abstract
Stage T1 bladder cancers have the highest progression and recurrence rates of all non-muscle-invasive bladder cancers (NMIBCs). Most T1 cancers are treated with bacillus Calmette-Guérin (BCG), but many will progress or recur, and some T1 patients will die from bladder cancer. Particularly aggressive tumors could be treated with early cystectomy. To better understand the molecular heterogeneity of T1 cancers, we performed transcriptome profiling...
Paper Details
Title
Identification of Differential Tumor Subtypes of T1 Bladder Cancer
Published Date
Oct 1, 2020
Volume
78
Issue
4
Pages
533 - 537
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.